Paired Vagus Nerve Stimulation (VNS) With Rehabilitation for Upper Limb Function Improvement After Stroke
- Conditions
- Stroke
- Interventions
- Device: Vivistim SystemOther: Rehab Only
- Registration Number
- NCT01669161
- Lead Sponsor
- MicroTransponder Inc.
- Brief Summary
Patients (UK only) at least 6 months post stroke, with upper limb deficits, may enroll. Patients will be randomized to one of two groups - a group implanted with a device that allows pairing VNS with rehabilitation and a group that only receives rehabilitation (no implant). Patients have two baseline evaluations, one evaluation after implant but before initiation of treatment, and then six weeks of rehabilitation or rehabilitation + VNS, followed by post acute therapy evaluations at 1, 7, and 30 days after the 6-weeks of treatment. The intent is to assess safety and provide preliminary effectiveness information for VNS for upper limb functional improvement after stroke. Implanted patients may receive longer-term treatment and follow-up after the acute study.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 21
- History of unilateral supratentorial ischemic stroke that occurred at least 6 months prior
- Age > 18 years and < 80 years
- Right or left sided weakness of upper extremity
Major
- Hemorrhagic stroke
- Any deficits in language or attention that interferes with reasonable study participation
- Presence of significant apraxia
- Profound Sensory loss
- Active major neurological or psychiatric diagnosis that would likely interfere with study protocol including alcohol or drug abuse
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description VNS Vivistim System VNS (vagus nerve stimulation) paired with rehabilitation as provided by the Vivistim System. Rehab Only Rehab Only Rehabilitation only (no implant, no VNS)
- Primary Outcome Measures
Name Time Method Safety 6-weeks Assessment of adverse events and serious adverse events.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
U. Glasgow / Western Infirmary
🇬🇧Glasgow, Scotland, United Kingdom